➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
McKinsey
AstraZeneca
Baxter
Boehringer Ingelheim

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for PROFESSIONAL DRUG COMPANY, INC. v. WYETH, INC. (D.N.J. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in PROFESSIONAL DRUG COMPANY, INC. v. WYETH, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for PROFESSIONAL DRUG COMPANY, INC. v. WYETH, INC. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-05-02 1 Complaint Application issued as U.S. Patent No. 6,274,171 Bl (“ ‘171 patent”). The ‘171 patent contains 25 claims in …method of use patents: the ‘171 patent, the ‘958 patent, and the ‘120 patent. These three patents ostensibly…Edgren patent qualifies as patent defeating prior art against the method of use patents as a patent application…despite knowing (i) an earlier Wyeth patent (the Upton patent) and a patent application by a Wyeth collaborator… three method of use patents, the ‘171, ‘958, and ‘120 patents. All three patents are, and have always External link to document
2011-06-22 19 Amended Complaint Application issued as U.S. Patent No. 6,274,171 B1 (“ ‘171 patent”). The ‘171 patent contains 25 claims in… of use patents: the ‘171 patent, the ‘958 patent, and the ‘120 patent. These three patents ostensibly…Edgren patent qualifies as patent defeating prior art against the method of use patents as a patent application… knowing (i) an earlier Wyeth patent (the Upton patent) and a patent application by a Wyeth collaborator…three method of use patents, the ‘171, ‘958, and ‘120 patents. All three patents are, and have always External link to document
2013-10-23 287 Amended Complaint venlafaxine: U.S. Patent Nos. 6,274,171 (“the ‘171 patent), 6,419,958 (“the ‘958 patent”), and 6,403,120…Application issued as U.S. Patent No. 6,274,171 B1 (the “ ‘171 patent”). The ‘171 patent contains 25 claims…been patented long ago in McAinsh et als., U.S. patent number 4,138,475 (the “McAinsh patent”), which…application issued as U.S. Patent No. 6,403,120 B1 (the “ ‘120 patent”). The ‘120 patent contains 14 claims… ‘958 patents. In the stark light of later patent infringement litigation, all three patents would External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Moodys
Baxter
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.